Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2150 of 2228 entries
View as:

Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BIRB 1017 BS as a Solution in PEG 400 / 26% Ethanol Administered to Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02184338 Org: User:
Start: 08/31/04 End: - Due: -

Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03971539 Org: User:
Start: 07/15/19 End: 10/26/20 Due: 10/26/21

Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT01132313 Org: User:
Start: 05/31/10 End: 10/31/14 Due: 10/31/15

Bioequivalence of Two Different Capsule Types of Dabigatran

Phase: N/A Priority: Normal
NCT ID: NCT01290757 Org: User:
Start: 01/31/11 End: - Due: -

Investigation of Ritonavir Effects on Afatinib Exposure in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01426958 Org: User:
Start: 08/31/11 End: - Due: -

Efficacy and Tolerability of Antistax® in Male and Female Patients Suffering From Chronic Venous Insufficiency

Phase: N/A Priority: Normal
NCT ID: NCT02191254 Org: User:
Start: 04/30/04 End: - Due: -

A Study in Healthy People to Test How 3 Different Formulations of BI 764198 Are Taken up in the Body and How This is Influenced by Food

Phase: N/A Priority: Normal
NCT ID: NCT06955754 Org: User:
Start: 05/20/25 End: 06/27/25 Due: 06/27/26

Metabolism and Pharmacokinetics of [14C] BEA 2180 BR Administered Orally Compared to [14C] BEA 2180 BR Administered Intravenously in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02258971 Org: User:
Start: 03/31/07 End: - Due: -

A Study to Compare Meloxicam IM Once Daily and Meloxicam Administered Orally Once Daily in Patients With Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00239395 Org: User:
Start: 07/31/04 End: 12/31/04 Due: 12/31/05

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT02770170 Org: User:
Start: 05/16/16 End: 08/18/20 Due: 08/18/21

Relative Bioavailability of Meloxicam 2 x 7.5 mg Tablets Compared to 15 mg Tablet and Dose Proportionality Over a Dose Range of 7.5 mg and 15 mg in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02276352 Org: User:
Start: 06/30/99 End: - Due: -

Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients

Phase: N/A Priority: Normal
NCT ID: NCT02239835 Org: User:
Start: 12/31/99 End: - Due: -

A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions

Phase: N/A Priority: Normal
NCT ID: NCT00144248 Org: User:
Start: 06/25/04 End: - Due: -

Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183337 Org: User:
Start: 02/28/07 End: - Due: -

Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)

Phase: N/A Priority: Normal
NCT ID: NCT01170065 Org: User:
Start: 06/25/10 End: 09/26/16 Due: 09/26/17

A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00042068 Org: User:
Start: 06/30/02 End: 07/31/03 Due: 07/31/04

This Study Tests How Different Doses of BI 690517 Are Taken up in the Body of Healthy Men. The Study Also Looks at How Food Influences the Amount of BI 690517 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT03100916 Org: User:
Start: 05/05/17 End: 11/24/17 Due: 11/24/18

A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver Problems

Phase: N/A Priority: Normal
NCT ID: NCT05731908 Org: User:
Start: 02/21/23 End: 04/13/23 Due: 04/13/24

Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin

Phase: N/A Priority: Normal
NCT ID: NCT02783040 Org: User:
Start: 09/30/15 End: 10/31/15 Due: 10/31/16

Relative Bioavailability of a Single Dose of Nintedanib Given Alone and in Combination With Multiple Doses of Rifampicin

Phase: N/A Priority: Normal
NCT ID: NCT01770392 Org: User:
Start: 01/31/13 End: 03/31/13 Due: 03/31/14

The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02249312 Org: User:
Start: 07/31/99 End: - Due: -

A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT03868540 Org: User:
Start: 03/28/19 End: 11/25/19 Due: 11/25/20

A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.

Phase: N/A Priority: Normal
NCT ID: NCT00390689 Org: User:
Start: 10/31/06 End: - Due: -

To Determine Blood Concentrations of Ibuprofen and Caffeine in a Tablet Against Ibuprofen Alone From Another Tablet

Phase: N/A Priority: Normal
NCT ID: NCT02629354 Org: User:
Start: 11/30/15 End: 01/31/16 Due: 01/31/17

This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03433898 Org: User:
Start: 02/23/18 End: 07/20/23 Due: 07/20/24